View in EDS HTML Full Text PDF Full Text

Author Correction: Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response.

Saved in:
Bibliographic Details
Title: Author Correction: Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response.
Authors: Szewczyk MM; Structural Genomics Consortium, University of Toronto, Toronto, ON, M5G 1L7, Canada., Ishikawa Y; Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Organ S; Structural Genomics Consortium, University of Toronto, Toronto, ON, M5G 1L7, Canada., Sakai N; Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Li F; Structural Genomics Consortium, University of Toronto, Toronto, ON, M5G 1L7, Canada., Halabelian L; Structural Genomics Consortium, University of Toronto, Toronto, ON, M5G 1L7, Canada., Ackloo S; Structural Genomics Consortium, University of Toronto, Toronto, ON, M5G 1L7, Canada., Couzens AL; Network Biology Collaborative Centre at the Lunenfeld-Tanenbaum Research Institute, 600 University Ave, Room 992, Toronto, ON, M5G 1X5, Canada., Eram M; Structural Genomics Consortium, University of Toronto, Toronto, ON, M5G 1L7, Canada., Dilworth D; Structural Genomics Consortium, University of Toronto, Toronto, ON, M5G 1L7, Canada., Fukushi H; Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Harding R; Structural Genomics Consortium, University of Toronto, Toronto, ON, M5G 1L7, Canada., Dela Seña CC; Structural Genomics Consortium, University of Toronto, Toronto, ON, M5G 1L7, Canada., Sugo T; Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Hayashi K; Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., McLeod D; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, ON, Canada., Zepeda C; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, ON, Canada., Aman A; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, ON, Canada., Sánchez-Osuna M; Institute for Research in Immunology and Cancer (IRIC) University of Montreal, 2950 Chemin de Polytechnique, Montreal, QC, H3T 1J4, Canada., Bonneil E; Institute for Research in Immunology and Cancer (IRIC) University of Montreal, 2950 Chemin de Polytechnique, Montreal, QC, H3T 1J4, Canada., Takagi S; Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Al-Awar R; Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, ON, Canada.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, M5S 1A8, Canada., Tyers M; Institute for Research in Immunology and Cancer (IRIC) University of Montreal, 2950 Chemin de Polytechnique, Montreal, QC, H3T 1J4, Canada., Richard S; Terry Fox Molecular Oncology Group and Bloomfield Center for Research on Aging, Lady Davis Institute for Medical Research and Departments of Oncology and Medicine, McGill University, Montreal, QC, H3T 1E2, Canada., Takizawa M; Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan., Gingras AC; Network Biology Collaborative Centre at the Lunenfeld-Tanenbaum Research Institute, 600 University Ave, Room 992, Toronto, ON, M5G 1X5, Canada., Arrowsmith CH; Structural Genomics Consortium, University of Toronto, Toronto, ON, M5G 1L7, Canada.; Princess Margaret Cancer Centre and Department of Medical Biophysics, University of Toronto, Toronto, ON, M5G 2M9, Canada., Vedadi M; Structural Genomics Consortium, University of Toronto, Toronto, ON, M5G 1L7, Canada.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, M5S 1A8, Canada., Brown PJ; Structural Genomics Consortium, University of Toronto, Toronto, ON, M5G 1L7, Canada., Nara H; Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan. nara@pharm.or.jp., Barsyte-Lovejoy D; Structural Genomics Consortium, University of Toronto, Toronto, ON, M5G 1L7, Canada. d.barsyte@utoronto.ca.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, M5S 1A8, Canada. d.barsyte@utoronto.ca.; Nature Research Center, Vilnius, Akademijos 2, Lithuania. d.barsyte@utoronto.ca.
Source: Nature communications [Nat Commun] 2020 May 26; Vol. 11 (1), pp. 2683. Date of Electronic Publication: 2020 May 26.
Publication Type: Journal Article; Published Erratum
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2041-1723
DOI:10.1038/s41467-020-16613-x